Researchers investigated the efficacy of a novel intra-tumoral drug delivery carrier in treating oral squamous cell carcinoma.
The Endpoints Slack interview: Cellino CEO Nabiha Saklayen on cell therapy’s future, Elon Musk and time travel
Nabiha Saklayen founded Cellino Biotech just as she was finishing her PhD in physics at Harvard in 2017, while she was still in her 20s.